Circulating and renal vein levels of microRNAs in patients with renal artery stenosis

Moo Yong Park, Sandra Herrmann, Ahmed Saad, Robert Jay Widmer, Hui Tang, Xiang Yang Zhu, Amir Lerman, Stephen C Textor, Lilach O Lerman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background MicroRNAs (miRs) are small non-coding RNAs that are important regulators of gene expression and have been implicated in atherosclerosis. Kidney injury distal to atherosclerotic renal artery stenosis (ARAS) is aggravated by atherosclerosis. Therefore, this study tested the hypothesis that renal miR expression would be altered in patients with ARAS. Methods Patients with essential hypertension (EH; n = 13) or ARAS (n = 13) underwent a 3-day protocol study under controlled conditions. For miR levels, blood samples were collected from EH and ARAS renal vein (RV) and inferior vena cava or peripheral vein of matched normotensive healthy volunteers (HV; n = 13) and patients with coronary atherosclerosis (CA; n = 11). Single-renal blood flow was measured in EH and ARAS using computer tomography to calculate renal gradients and release of miRs. Results Glomerular filtration rate (GFR) was lower in ARAS compared with the other groups. Systemic levels of most miRs were elevated in CA. RV miR levels were lower than systemic levels in both ARAS and EH. GFR-adjusted RV levels of miR-21, 155 and 210 were reduced only in ARAS patients compared with systemic levels in HV, although cross-kidney gradients were not different from EH. RV levels of miR-21, 126, 155 and 210 correlated with GFR. Conclusions Levels of atherosclerosis-related miR-21, 126, 155 and 210 are decreased in the stenotic-kidney vein of ARAS compared with EH patients, likely due to decreased GFR. Yet, these miRs might be implicated in modulating renal injury in ARAS, and their RV level may be a marker reflecting their renal expression.

Original languageEnglish (US)
Pages (from-to)480-490
Number of pages11
JournalNephrology Dialysis Transplantation
Volume30
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Renal Artery Obstruction
Renal Veins
MicroRNAs
Kidney
Glomerular Filtration Rate
Atherosclerosis
Veins
Small Untranslated RNA
Renal Circulation
Wounds and Injuries
Inferior Vena Cava
Regulator Genes
Coronary Artery Disease
Healthy Volunteers
Tomography
Gene Expression

Keywords

  • atherosclerosis
  • microRNA
  • renal artery stenosis

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Circulating and renal vein levels of microRNAs in patients with renal artery stenosis. / Park, Moo Yong; Herrmann, Sandra; Saad, Ahmed; Widmer, Robert Jay; Tang, Hui; Zhu, Xiang Yang; Lerman, Amir; Textor, Stephen C; Lerman, Lilach O.

In: Nephrology Dialysis Transplantation, Vol. 30, No. 3, 01.03.2015, p. 480-490.

Research output: Contribution to journalArticle

@article{4248f446b77143e6bcc294ae78c810ff,
title = "Circulating and renal vein levels of microRNAs in patients with renal artery stenosis",
abstract = "Background MicroRNAs (miRs) are small non-coding RNAs that are important regulators of gene expression and have been implicated in atherosclerosis. Kidney injury distal to atherosclerotic renal artery stenosis (ARAS) is aggravated by atherosclerosis. Therefore, this study tested the hypothesis that renal miR expression would be altered in patients with ARAS. Methods Patients with essential hypertension (EH; n = 13) or ARAS (n = 13) underwent a 3-day protocol study under controlled conditions. For miR levels, blood samples were collected from EH and ARAS renal vein (RV) and inferior vena cava or peripheral vein of matched normotensive healthy volunteers (HV; n = 13) and patients with coronary atherosclerosis (CA; n = 11). Single-renal blood flow was measured in EH and ARAS using computer tomography to calculate renal gradients and release of miRs. Results Glomerular filtration rate (GFR) was lower in ARAS compared with the other groups. Systemic levels of most miRs were elevated in CA. RV miR levels were lower than systemic levels in both ARAS and EH. GFR-adjusted RV levels of miR-21, 155 and 210 were reduced only in ARAS patients compared with systemic levels in HV, although cross-kidney gradients were not different from EH. RV levels of miR-21, 126, 155 and 210 correlated with GFR. Conclusions Levels of atherosclerosis-related miR-21, 126, 155 and 210 are decreased in the stenotic-kidney vein of ARAS compared with EH patients, likely due to decreased GFR. Yet, these miRs might be implicated in modulating renal injury in ARAS, and their RV level may be a marker reflecting their renal expression.",
keywords = "atherosclerosis, microRNA, renal artery stenosis",
author = "Park, {Moo Yong} and Sandra Herrmann and Ahmed Saad and Widmer, {Robert Jay} and Hui Tang and Zhu, {Xiang Yang} and Amir Lerman and Textor, {Stephen C} and Lerman, {Lilach O}",
year = "2015",
month = "3",
day = "1",
doi = "10.1093/ndt/gfu341",
language = "English (US)",
volume = "30",
pages = "480--490",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Circulating and renal vein levels of microRNAs in patients with renal artery stenosis

AU - Park, Moo Yong

AU - Herrmann, Sandra

AU - Saad, Ahmed

AU - Widmer, Robert Jay

AU - Tang, Hui

AU - Zhu, Xiang Yang

AU - Lerman, Amir

AU - Textor, Stephen C

AU - Lerman, Lilach O

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background MicroRNAs (miRs) are small non-coding RNAs that are important regulators of gene expression and have been implicated in atherosclerosis. Kidney injury distal to atherosclerotic renal artery stenosis (ARAS) is aggravated by atherosclerosis. Therefore, this study tested the hypothesis that renal miR expression would be altered in patients with ARAS. Methods Patients with essential hypertension (EH; n = 13) or ARAS (n = 13) underwent a 3-day protocol study under controlled conditions. For miR levels, blood samples were collected from EH and ARAS renal vein (RV) and inferior vena cava or peripheral vein of matched normotensive healthy volunteers (HV; n = 13) and patients with coronary atherosclerosis (CA; n = 11). Single-renal blood flow was measured in EH and ARAS using computer tomography to calculate renal gradients and release of miRs. Results Glomerular filtration rate (GFR) was lower in ARAS compared with the other groups. Systemic levels of most miRs were elevated in CA. RV miR levels were lower than systemic levels in both ARAS and EH. GFR-adjusted RV levels of miR-21, 155 and 210 were reduced only in ARAS patients compared with systemic levels in HV, although cross-kidney gradients were not different from EH. RV levels of miR-21, 126, 155 and 210 correlated with GFR. Conclusions Levels of atherosclerosis-related miR-21, 126, 155 and 210 are decreased in the stenotic-kidney vein of ARAS compared with EH patients, likely due to decreased GFR. Yet, these miRs might be implicated in modulating renal injury in ARAS, and their RV level may be a marker reflecting their renal expression.

AB - Background MicroRNAs (miRs) are small non-coding RNAs that are important regulators of gene expression and have been implicated in atherosclerosis. Kidney injury distal to atherosclerotic renal artery stenosis (ARAS) is aggravated by atherosclerosis. Therefore, this study tested the hypothesis that renal miR expression would be altered in patients with ARAS. Methods Patients with essential hypertension (EH; n = 13) or ARAS (n = 13) underwent a 3-day protocol study under controlled conditions. For miR levels, blood samples were collected from EH and ARAS renal vein (RV) and inferior vena cava or peripheral vein of matched normotensive healthy volunteers (HV; n = 13) and patients with coronary atherosclerosis (CA; n = 11). Single-renal blood flow was measured in EH and ARAS using computer tomography to calculate renal gradients and release of miRs. Results Glomerular filtration rate (GFR) was lower in ARAS compared with the other groups. Systemic levels of most miRs were elevated in CA. RV miR levels were lower than systemic levels in both ARAS and EH. GFR-adjusted RV levels of miR-21, 155 and 210 were reduced only in ARAS patients compared with systemic levels in HV, although cross-kidney gradients were not different from EH. RV levels of miR-21, 126, 155 and 210 correlated with GFR. Conclusions Levels of atherosclerosis-related miR-21, 126, 155 and 210 are decreased in the stenotic-kidney vein of ARAS compared with EH patients, likely due to decreased GFR. Yet, these miRs might be implicated in modulating renal injury in ARAS, and their RV level may be a marker reflecting their renal expression.

KW - atherosclerosis

KW - microRNA

KW - renal artery stenosis

UR - http://www.scopus.com/inward/record.url?scp=84924373349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924373349&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfu341

DO - 10.1093/ndt/gfu341

M3 - Article

C2 - 25362000

AN - SCOPUS:84924373349

VL - 30

SP - 480

EP - 490

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 3

ER -